Dyve Biosciences Announces Chuck Harbert, Ph.D. to Join as Chief Scientific Officer
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Dyve Biosciences, Inc. today announced that longtime Pfizer Executive Chuck Harbert, Ph.D. has joined the company in…
Pharmaceuticals, Biotechnology and Life Sciences
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Dyve Biosciences, Inc. today announced that longtime Pfizer Executive Chuck Harbert, Ph.D. has joined the company in…
Pear is pioneering the use of software to treat disease with Prescription Digital Therapeutics (PDTs) for a range of unmet…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment…
MUMBAI, India–(BUSINESS WIRE)–As part of its ongoing effort to establish a global development network, Rubicon Research Private Limited, a leading…
Cancer Research UK to fund exploratory development of BT7401 through a Phase IIa clinical study LONDON & CAMBRIDGE, England &…
Industry veteran brings broad commercial expertise in neuroscience drug development and commercialization as Alzheon advances ALZ-801 into Phase 3 as…
FRAMINGHAM, Mass.–(BUSINESS WIRE)–Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease (AD)…
WILMINGTON, Del.–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) today announced the validation of the Company’s Marketing Authorization Application (MAA) for pemigatinib for the treatment…
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Boehringer Ingelheim’s discovery programmes CAMBRIDGE, England–(BUSINESS WIRE)–PhoreMost Limited, the…
NEW YORK–(BUSINESS WIRE)–$BMY—Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its previously announced divestment of its oral solid,…